ANTG is a proudly Australian, independently owned medicinal cannabis focused company.
We are motivated by the possibilities and health benefits that medicinal cannabis offers.
We combine a strong research focus with best in class cultivation and extraction systems to produce exclusive high quality cannabinoid-based medical treatments that can meet individual patient needs.
“Our pioneering approach is underpinned by deep expertise and a commitment to reduce suffering and improve people’s lives through the research, development and clinical application of cannabinoid-based medical treatments”
MATT CANTELO, ANTG CHIEF EXECUTIVE OFFICER.
Perth’s first medicinal cannabis clinic has been opened in Subiaco. This clinic is the fourth location in Australia and has been set up to streamline access to medicinal cannabis and help to speed up the application process.
A new law has been passed by the New Zealand Government which will allow terminally ill patients to access cannabis for medicinal use. The law will also allow medicinal cannabis to be manufactured in the country and exported overseas. New regulations are expected to be in place within a year.
Matt Cantelo recently sat down with leading business publication, My Business to discuss the future of the Australian medicinal cannabis industry, ANTG’s plans for growth, the role of the industry to facilitate greater research and ANTG’s exciting partnership to export Australian grown cannabis to the German market.
A new world-first trial will examine whether oral medicinal cannabis can affect tumour growth in patients with glioma, a common type of brain cancer.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.
LEARN ABOUT ANTG HERE >
